Objective: To evaluate the effectiveness of patient decision aids (PtDA) compared to usual education on appropriate and timely access to total joint arthroplasty in patients with osteoarthritis. Method: A randomized controlled trial (RCT) with patients undergoing orthopedic screening. Control and intervention arms received usual education; intervention arm also received a PtDA and a surgeon preference report. Wait times (primary outcome) were described using stratified KaplaneMeier survival curves with patients censored at the time of death or loss to follow-up, and multivariable Cox proportional hazards regression. Secondary outcomes were compared using stratified Cochran-Mantel-Haenszel chi-squared tests. Results: 343 patients were randomized to intervention (n ¼ 174) or control (n ¼ 169). The typical patient was 66 years old, retired, living with someone, and 51% had high school education or less. The intervention was associated with a trend towards reduction in wait time (hazard ratio (HR) 1.25, 95% confidence interval (CI) 0.99e1.60, P ¼ 0.0653). Median wait times were 3 weeks shorter in intervention than in control at the community site with no difference at the academic site. Good decision quality was reached by 56.1% intervention and 44.5% control (Relative risk (RR) 1.25; 95% CI 1.00e1.56, P ¼ 0.050). Surgery rates were 73.2% intervention and 80.5% controls (RR 0.91: 95% CI 0.81e1.03) with 12 intervention (7.3%) and eight control participants (4.9%) returning to have surgery within 2 years (P ¼ 0.791). Conclusion: Compared to controls, decision aid recipients had shorter wait times at one site, fewer surgeries, and were more likely to reach good decision quality, but overall effect was not statistically significant. Trials registration: The full trial protocol is available at ClinicalTrials.Gov (NCT00911638).
Introduction
There is growing demand for hip and knee arthroplasty with increased osteoarthritis, obesity, and older adults' desire to maintain a high level of physical activity 1 . Surgical demand can be addressed by considering the need for more resources while ensuring appropriate use of joint arthroplasty. Patients are appropriate for joint arthroplasty when pain and functional limitations interfere with their quality of life despite use of conservative treatment 2, 3 . Patient preferences are another important element of appropriateness 3, 4 . However, patient preferences are often influenced by unrealistic expectations, and expectations subsequently influence satisfaction with joint arthroplasty 5e7 . In fact, many patients agree to surgical referral for management of joint pain without adequate knowledge or consideration of their options 8e10 . Interventions are required to realign patients' expectations and ensure patient preferences inform appropriate use of joint arthroplasty.
Patient decision aids (PtDA) communicate evidence on treatment options in patient-friendly terms and guide patients through a decision making process 11 . Three randomized controlled trials (RCT) have evaluated PtDA effects on patients with osteoarthritis considering hip and/or knee arthroplasty 12e14 . All trials used PtDAs (e.g., digital video-disc and booklet) produced by the Informed Medical Decisions Foundation and one trial 12 included a health coach to help patients navigate the decision making process. Compared to controls, patients in the PtDA group experienced less decisional conflict, felt more informed, and were better prepared for the surgical consultation. As well, orthopedic surgeons in the trial with health coaches reported greater satisfaction, consultation efficiency, and patients asked more relevant questions 12 . Trials of PtDAs for other treatment decisions have increased realistic expectations and achieved choices based on informed patients' preferences 11 .
PtDAs may also improve timely access to treatment of osteoarthritis. For example, using PtDAs may identify patients who never intend to have surgery by helping them understand their treatment options and clarify their informed preferences before the surgical referral. As well, patients exposed to PtDAs prior to surgical consultation may be better prepared, making the visit more efficient by optimizing the surgeons' time and the consent process 12, 15 . PtDAs can reduce patients' decisional conflict and those with less decisional conflict are less likely to change their mind or delay decision making 16, 17 .
In preparation for this study, we conducted a pilot RCT 14 . Compared to usual care, patients given the PtDA were more knowledgeable (71% vs 47%; P < 0.001) and a higher proportion achieved good decision quality (56% vs 25%; P < 0.001). Given that 13% of patients were on the surgical wait list after 1 year, we determined that subsequent studies would require longer followup to evaluate the impact of PtDAs on wait time outcomes.
The overall aim of this study was to evaluate the effectiveness of PtDAs compared to usual education on appropriate and timely access to total joint arthroplasty in patients with osteoarthritis. We hypothesized that PtDAs would influence the quality of decisions and timeliness of joint arthroplasty for those who prefer it and have osteoarthritis severe enough to require it.
Method

Design
A prospective multicenter, parallel group, single blind, two-arm RCT with equal randomization (1:1), was conducted based on the Ottawa Decision Support Framework 18 . This framework asserts that decision support tailored to unresolved decisional needs (i.e., inadequate knowledge, unrealistic expectations, unclear values, inadequate support) improves decision quality defined as informed choice based on patient preferences. Patients whose decisional needs are unresolved are more likely to delay decisions, change their mind, feel regret, express dissatisfaction, and blame the practitioner for poor outcomes 16, 17 . In compliance with the Helsinki Declaration, participating hospitals' Research Ethic Boards approved this study. We made two changes from the trials registry protocol to the current study: (1) follow-up data collection was expanded to include email; and (2) decisional regret was not measured due to surgical wait time variability. Cost-effectiveness and quality of life will be reported elsewhere.
Setting
Patients were recruited from two orthopedic screening clinics in Eastern Ontario, Canada (i.e., academic teaching hospital and large community hospital). Patients were asked to self-report pain, stiffness, and function using the validated Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index 19 . A sports medicine physician (site 1), advanced practice physiotherapist (site 2), or nurse practitioner (site 2) assessed surgical candidacy using the 7-item Western Canada Wait List Hip Knee Priority Tool mapped onto three guideline criteria indicating minimally appropriate for considering joint arthroplasty (moderate to severe pain, moderate to severe functional limitations, abnormal radiographic findings) 20 . At both clinics, appropriate patients were given standard hospital information on joint replacement surgery (i.e., preparation for surgery, recovery after surgery, discharge plans). This standard written information did not include surgical benefits and harms, alternative options, or anything that could support decision making. Appropriate patients were then referred to an orthopedic surgeon (7 surgeons at site 1; 6 at site 2).
Participants
Eligible adults aged 18 or over had moderate or severe hip or knee radiographic osteoarthritis and were determined at the orthopedic screening clinic to be appropriate for surgical consultation about joint arthroplasty 8 . Patients with inflammatory arthritis, previous joint arthroplasty surgical consultation, or osteotomy were ineligible. In addition, patients were excluded if they had noncorrected hearing or visual impairment, were unable to read or understand English, or did not have access to a television with a VCR or DVD player.
Interventions
The intervention group received standard patient education, a PtDA and a preference report for the surgeon. The PtDAs were titled Treatment choices for hip osteoarthritis and Treatment choices for knee osteoarthritis; 50-min videos and booklets produced by the Informed Medical Decisions Foundation. Both PtDAs met the International Patient Decision Aid Standards criteria by making explicit the decision and providing evidence-based information on treatment options, benefits and risks, and related probabilities 21 . They included patients' testimonials (e.g., describing treatment options, their decision making process experiences, and outcomes) that help patients clarify their values associated with option outcomes. Additional details are available at https://decisionaid.ohri. ca/cochinvent.php. Patients' knowledge, values, preferred treatment choice, and decisional conflict were assessed using a questionnaire formatted as a user-friendly leaflet. These findings were combined with patients' clinical assessment results to create a onepage preference report for the surgeon 14 .
The control intervention consisted of standard patient education and surgeons received a half-page summary of patients' clinical assessment findings only.
Procedures
Eligible patients met with a research assistant who obtained written consent, demographic information and the WOMAC Index and Hip and Knee Replacement Priority Criteria Tool results 19, 20 . These baseline data were used to populate the surgeon's clinical summary report. To ensure concealment, call-in telephone software was used to obtain randomized allocation. Patients were stratified by affected joint (hip/knee) and site. They were then randomized to the control or intervention group. The allocation schedule was computer-generated centrally by a statistician, using block randomization, with randomly varying block lengths of 4, 6, or 8. To minimize bias after allocation, patients reviewed the information (i.e., PtDA plus usual education or usual education only) at home, were not informed of the other intervention, and did not have contact with orthopedic screening clinic practitioners during the 2 weeks post clinic visit when measures were collected. Although the research assistant was not blinded to group allocation, the primary outcome was objective and used clinic data.
Within 2 weeks of recruitment, the research assistant telephoned participants to obtain their answers to the hip-knee osteoarthritis decision quality, decisional conflict, preferred treatment option, and preparation for decision making instruments. This information was added to the surgeon's clinical summary report to create a preference report for surgeons 14 . Participants were contacted by telephone 6 months after recruitment to administer the decisional conflict questionnaire and determine whether they had seen the orthopedic surgeon, and if so, whether they had chosen surgery or alternative non-surgical options. Participants were contacted again at 12, 18, and 24 months to determine if they had a surgical consultation and whether they had chosen surgery or nonsurgical options. Surgeon consultation and surgery dates were collected from the clinic records.
Sample size
The sample size was calculated for total wait times and informed by our pilot study 14 . We determined that 155 patients were needed per group, followed for 2 years, to detect a clinically important difference of 8 weeks in mean total wait times using a two-sided t-test at the 5% level of significance with 80% power, assuming a common standard deviation (SD) of 25 weeks. The clinically important difference of 8 weeks was chosen after discussion with clinical experts on the research team. To account for 10% loss to follow-up, our target enrolment was 173 patients per group.
Outcomes
The primary outcome was the wait times calculated by the number of days from screening that determined appropriate for surgical consultation to implementation of the definitive choice (i.e., surgery date or date of decision to decline the surgery, either explicitly stated or based on the date the appointment was cancelled without rebooking). Once patients have surgery or decide not to have surgery, they are removed from the wait list. National joint arthroplasty wait time benchmark is 26 weeks from surgical consultation to surgery 22, 23 .
Secondary outcomes, based on the International Patient Decision Aid Standards, were good decision quality, realistic expectation of outcomes, surgical rates within 2 years, and perceptions of the decision making process 21 . Good decision quality was defined by a patient score >66% on the knowledge test and if their predicted probability of surgery based on values corresponded with their actual choice 14 . Realistic expectations were the proportion of patients who correctly indicated the chances of an outcome in a subset of knowledge test questions. Surgical rates were determined by the proportion of patients who proceeded to surgery within 2 years, based on clinic data. For patients who chose non-surgical options, return to the waitlist was measured. Patients' perceptions of the quality of the decision making process were measured using the Decisional Conflict and Preparation for Decision Making Scales 24e26 .
Outcome instruments
Hip-knee osteoarthritis decision quality instrument was used to assess patients' decision quality with multiple-choice questions examining knowledge (18 items) and values (7 items) 27 . This instrument is reproducible and demonstrates discriminant, content, and predictive validity. The 5-item screener knowledge score was used in the decision quality calculation and a sub-set of three questions for determining realistic expectations of outcomes. These 5-items measure knowledge relevant to surgery and have high reproducibility with total knowledge score (Pearson correlation coefficients >0.92, P < 0.001).
Decisional conflict scale, measured using the SURE tool version, assessed patients' perception of feeling sure, informed, supported, and clear about what mattered most 25 . The SURE tool showed adequate internal consistency (KudereRichardson 20 coefficient of 0.7) and was significantly correlated with the original Decision Conflict Scale 26 .
For Preparation for decision making scale, 4 of the original 10 items were used given their relevance to International Patient Decision Aid Standards for evaluating decision processes 21 . These items discriminated between patients who were and were not prepared for decision making. Discrimination values for these items were excellent, ranging from 2.1 to 3.4 24 .
Data management and statistical methods
All data were analyzed using SAS v. 9.3. The primary outcome (wait time from screening to implementation of the definitive choice) was described using KaplaneMeier survival curves for each site; the median wait times with 95% confidence intervals (CIs) were calculated for each group. To assess the statistical significance of the PtDA on the primary outcome, we used multivariable Cox proportional hazards regression controlling for site and joint (hip or knee). Results were expressed as hazard ratios (HRs) with 95% CI. The proportional hazards assumption was tested using martingale residuals. Patients were censored at the end of the study, at the time of death, or loss to follow-up.
Dichotomous secondary outcomes (e.g., proportions reaching good decision quality, surgery rates, congruence between patients' choice and their values, SURE test) were compared between groups using Cochran-Mantel-Haenszel chi-squared tests, controlling for site. The BresloweDay test for homogeneity was used to examine heterogeneity across sites. The relative difference in proportions between the intervention and control arms was calculated as Relative Risk (RR) with 95% CIs; if important qualitative interaction was detected, separate RR estimates were calculated for each site.
The predicted probability of surgery, used to calculate good decision quality and congruence between patients' choice and values, was calculated for each patient using a logistic regression equation. The equation was derived using the approach in 14 : In particular, stepwise backwards elimination was used to identify independent variables from the seven values items on the Hip-Knee Osteoarthritis Decision Quality Instrument. The predicted probability of surgery was calculated as ½1 þ expðÀSÞ À1 where S ¼ À0:5327 þ ðÀ0:1569 Â ValueQ 11Þ þ ð0:1115 Â ValueQ 14Þ þ ð0:2843 Â ValueQ 17Þ where Q11 was avoiding surgery, Q14 was avoiding prescription pain medication, and Q17 was avoid pain remaining the same. Good decision quality was then calculated as a dichotomous indicator, defined as scoring >66% on the knowledge test and having a predicted probability !0.5 for a patient with surgery or predicted probability <0.5 for a patient without surgery 27 .
The mean knowledge test scores and Preparation for Decision Making were compared between the two groups using the twosample t-test. Fisher's exact test was used in the case of small expected number of events. Tests were conducted at the two-sided 5% level of significance.
Results
Participant flow
Between May 2008 and October 2009, 343 participants were randomized to the intervention (n ¼ 174) or usual care (n ¼ 169) and followed for 2 years (Fig. 1) . Common reasons for ineligibility were mild osteoarthritis, previous arthroplasty, and language barriers. Baseline data were available for only 167 in each arm and findings were analyzed based on participants' original assigned groups. The typical participant was 66 years old, retired, living with someone else, and 51% had high school education or less (Table I) . Participants were considering knee arthroplasty (n ¼ 242) or hip arthroplasty (n ¼ 92). There was no statistically significant baseline differences between the groups based on demographic characteristics or osteoarthritis severity that were self-reported or practitioner-reported.
At the end of the 2-year follow-up (October 2011), there were 165 intervention group participants and 163 controls included in the primary outcome analysis. In the intervention group, two participants were missing wait time data and five were ineligible because they were awaiting MRI results for diagnosis, had a meniscal tear, underwent osteotomy, did not have osteoarthritis, or VCR was broken. In the control group, three were missing wait time data, one was having hip resurfacing not total hip arthroplasty, and two were ineligible because one was treated at a non-participating hospital and another was recruited for knee osteoarthritis but surgeon treated hip osteoarthritis resulting in the participant receiving the wrong PtDA/questionnaires.
Primary outcome
The KaplaneMeier estimate of the median time from recruitment to off the wait list across both sites was 16.9 weeks for the intervention group (n ¼ 165; 95% CI: 15.6, 20.0) and 20.6 weeks for the control group (n ¼ 163; 95% CI: 17.3, 23.4); wait times for 27 in the intervention and 32 in the control arms were censored. The site-specific median wait times were 15 weeks (95% CI 11.3e16.7) in intervention vs 18 weeks (95% CI 16.0e20.6) in control at the community site (Fig. 2) , and 27.9 weeks (95% CI 20.9e35.4) in intervention vs 28.0 weeks (95% CI 19.9e38.0) in control at the academic site (Fig. 3) . The Cox proportional hazards regression analysis controlling for site and joint yielded HR ¼ 1.25 (95% CI 0.99e1.60, P ¼ 0.0653) (an HR greater than 1 indicates shorter wait time).
Secondary outcomes
Good decision quality, defined as informed choice that matched their values, was achieved by 87 (56.1%) in the intervention and 69 (44.5%) in the control groups (RR 1.25; 95% CI: 1.00, 1.56, P ¼ 0.050) (Table II) . Mean total knowledge score for the intervention group was 12.4 out of 18 (SD 2.79) compared to 11.0 (SD 3.25) control group (P < 0.001).
Realistic expectations were statistically significantly higher for the intervention compared to control groups for correctly knowing the proportion of patients post-arthroplasty who would be able to walk with less pain after surgery (79.5%; 67.1%) and have serious complications from surgery (80.1%; 57.3%) (Table II) . Both groups scored poorly on the number of months for full recovery (9.6%; 5.7%).
Surgery rates were 120 of 164 (73.2%) for intervention and 132 of 164 (80.5%) for control (RR ¼ 0.91; 95% CI: 0.81, 1.03, P ¼ 0.121) (Table III) . Within 2 years, 12 patients in the intervention group (7.3%) and eight from the control group (4.9%) that chose nonsurgical options returned to the surgical wait list (P ¼ 0.791). Table III shows changes in patients' preferred treatment option post-intervention or after seeing the surgeon.
Perceptions of the decision making process. Post-intervention and before consultation with the surgeon, significantly more patients in the intervention arm than in the control arm felt informed (93.6% vs 79.6%, P < 0.001) and had clarity about which benefits and risks mattered most to them (88.5% vs 79.6%, P ¼ 0.044) (Table IV) . There were no statistically significant differences in the proportions of patients feeling supported (P ¼ 0.277) or feeling sure about the best choice (P ¼ 0.235). There were no statistically significant differences between groups in the proportions of patients achieving 4 out of 4 on the SURE test prior to the surgeon visit (P ¼ 0.347) or after consultation with the surgeon (6 months) (P ¼ 0.306).
Post-intervention and prior to the consultation, the intervention compared to control groups were more likely to know that the decision depended on their values (4.4 vs 4.0 out of 5; P ¼ 0.003) and felt more prepared to talk to their surgeon about what matters most to them (4.5 vs 4.1; P ¼ 0.014) (Table V) . There were no statistically significant differences between groups for recognizing that a decision needed to be made or thinking about how involved they wanted to be in making that decision.
Discussion
Our study sought to examine the effects of a PtDA on appropriate and timely access to hip or knee arthroplasty for patients with osteoarthritis. Controlling for site (academic vs community hospital) and joint (hip or knee), a non-statistically significant trend was observed whereby the PtDA decreased the time to removal from the wait list for patients given the PtDA (P-value ¼ 0.0653). Hence, the PtDA reduced wait times for patients on the surgery waiting list by removing the patients that do not want surgery or do not need surgery as observed in the lower proportion of patients in the PtDA group electing to have surgery. The effect of the PtDA varied between the sites: at the community site patients given the PtDA waited 3 weeks less from screening to definitive choice; however, at the academic site, there was no difference in wait times. The substantial heterogeneity across the sites needs to be explored. Despite the lack of statistical significance in decision quality, there was a 12% improvement in those exposed to the PtDA and significantly more patients had realistic expectations on two important outcomes of joint arthroplasty (i.e., pain relief when walking, serious surgical complications).
This study was conducted in two different clinics that were established to screen out patients with milder osteoarthritis, and as expected, most patients in the study had more severe osteoarthritis and were appropriate for considering surgery. Our findings indicate a trend in that a higher proportion of patients exposed to the PtDA achieved decision quality and waited fewer weeks. However, the PtDA may have greater effect and discrimination aimed at patients with earlier stages of osteoarthritis and may help them consider their non-surgical options. When non-surgical therapies have yielded limited success and pain becomes unmanageable, total joint arthroplasty is an effective surgical procedure 2, 28 .
In our study, patients who used the PtDA had statistically significantly higher knowledge scores, felt clearer about their values, and felt better prepared for the surgical consultation. These findings were similar to our pilot study evaluating the PtDA alone and another study that prepared patients with the same PtDA plus decision coaching 12, 14 thereby questioning use of coaching as a more expensive intervention 29 . However, a systematic review of 44 studies revealed that patients' capacity to participate in decision making was most strongly influenced by lack of knowledge on options and their preferences, as well as power imbalances 30 . PtDAs have consistently improved knowledge and helped patients clarify their preferences but little is known about ways to address power imbalances within the patient-surgeon consultation. Patients have suggested that nurses could address this power-imbalance by listening to their preferences and ensuring physicians know their preferences 30 . In our study, we used the 1-page preference report to communicate patients' knowledge and preferences to the surgeon together with their osteoarthritis severity. Patients were followed for 2 years after exposure to a PtDA about joint arthroplasty which allowed us to measure whether or not patients who initially chose non-surgical options subsequently changed their mind and returned to the surgery wait list. Although it was not statistically significant, we found an initial decrease in surgical rates in the PtDA group compared to controls (73% vs 81%) and few patients who subsequently changed their mind to have surgery in the PtDA group (7%) or control group (5%). Previous trials indicate that PtDAs can moderate surgical rates by addressing under-use of surgical procedures that informed patients need and want, and preventing over-use of procedures that informed patients do not value 11, 31 . For example, PtDAs reduced preference for surgery by 21% (e.g., hysterectomy, mastectomy, prostatectomy, coronary bypass surgery) in regions with high surgical rates in favor of more conservative options without compromising patient satisfaction or health outcomes. In regions with low surgical rates (e.g., prostatectomy in UK), surgery rates increased after patients were exposed to a PtDA 11, 32 . In our study, the 7% decrease observed in the intervention compared to the control groups was also likely influenced by the pre-surgical screening of patients. A previous study reported that half of patients screened at site 1 were referred back to primary care because their osteoarthritis did not meet the surgical appropriateness criteria (e.g., pain and functional limitations interfere with their quality of life despite use of conservative treatment) 8 .
A higher proportion of patients reached good decision quality in the PtDA group compared to controls who received usual education only. Decision quality is the gold standard measure for determining PtDA effectiveness 21 . It is calculated using a composite score that accounts for being informed (knowledge score) and achieving values-choice concordance 33, 34 . Values clarification was measured by asking patients to rate the 7-items in the Hip-Knee Decision Quality Instrument on a leaning scale of 1 (not at all important) to 10 (very important). Patients in the intervention group also felt clearer about their values and better prepared for discussing them with the surgeon. Using this leaning scale approach to values clarification is easier and more transparent for patients compared to other values clarification approaches such as conjoint analysis 13 . Our decision quality findings are consistent with our pilot study 14 and in the same direction as the meta-analysis in the Cochrane review of PtDA trials that showed a 51% improvement in informed values-based choices using various measures 11 .
Our study addresses concerns that a previous trial did not reflect usual practice or include typical patients 35 . For our study, patient recruitment occurred in a pre-surgical screening clinic that is usual practice for referral to orthopedic specialists in our community. Our eligibility criteria were inclusive. As a result, half of our participants had high school education or less and half had household incomes at or below the median income ($58,000) for couples aged 65 or older in Canada. Although the video feature of the PtDA we used made it easier to reach individuals with lower education and lower health literacy 36 , we did not assess participants' health literacy.
Limitations
Several limitations must be considered when interpreting the results of this trial. There was potential for self-report bias given that decision quality components, decisional conflict, and preparation for decision making are all patient reported. However, for the primary outcome of wait times, patient reported data was triangulated with data from the clinic records. Although we provided surgeons with a patient preference report summarizing patients' clinical data together with their knowledge, values for outcomes of options, and preferences, we did not measure if surgeons looked at the report or its influence on the consultation. Finally, this was a pragmatic trial in that we did not aim to standardize the usual clinical flow across sites but rather evaluated the effectiveness of the PtDA within two sites. However, accounting for two sites increased variability in the findings.
Conclusions
Using PtDAs for patients with osteoarthritis considering hip or knee arthroplasty appears to have optimized the surgical referral by enhancing patients' knowledge, ensuring realistic expectations of outcomes of options, and helping patients be clear about what matters most. However, despite having a trend towards shorter wait time in the PtDA group, this was observed at only one site and the overall effect was not statistically significant. Further research is required to measure the effect of PtDAs with the one-page preference report for surgeons on shared decision making within the consultation. 
